Colette Shen, MD, PhD

Dr Colette Shen discusses the promising future of NBTXR3 in cancer treatment, exploring its potential across various tumor types and ongoing trials.

Dr. Colette Shen discusses promising safety and efficacy results of NBTXR3 in treating recurrent head and neck cancer, highlighting unexpected patient responses.

Dr Colette Shen discusses the innovative Study 1100, exploring NBTXR3's safety and efficacy in treating recurrent head and neck cancer.

Discover how NBTXR3 enhances radiation therapy for head and neck cancer, boosting treatment efficacy while protecting healthy tissue.

Dr. Colette Shen discusses unmet needs in recurrent head and neck cancer, highlighting a novel treatment study aimed at improving patient outcomes.

Innovative NBTXR3 shows promise in enhancing radiotherapy for recurrent head and neck cancer, potentially transforming treatment options for patients.